Your Location:
Home >
Browse articles >
Mechanism of Xianglian Huazhuo Prescription Against Chronic Atrophic Gastritis Based on Network Pharmacology and Experimental Verification
Mechanism of Xianglian Huazhuo Prescription Against Chronic Atrophic Gastritis Based on Network Pharmacology and Experimental Verification
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 18, Pages: 161-168(2022)
DOI: 10.13422/j.cnki.syfjx.20220614
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 2 )
References
Publication Info
Metrics
319
Views
178
Downloads
10
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Xianglian Huazhuo Prescription Regulates Nrf2/NQO1/HO-1 Signaling Pathway to Affect Oxidative Stress in Treatment of Chronic Atrophic Gastritis
Xianglian Huazhuo Prescription Regulates miR-34b-5p/PFKFB1 Signaling Pathway to Inhibit Glycolysis and Ameliorate Chronic Atrophic Gastritis
Xianglian Huazhuo Prescription Regulates GP73/PERK/ATF4 Signaling Pathway to Influence Endoplasmic Reticulum Stress and Ameliorate Chronic Atrophic Gastritis
Xianglian Huazhuo Prescription Ameliorates Chronic Atrophic Gastritis via Regulating Lysosomal Iron Metabolism
Investigating Effect of Xianglian Huazhuo Prescription on Cell Cycle and Proliferation in Rats with Chronic Atrophic Gastritis Through TGF-β1/Smads Signaling Pathway
Related Author
LI Xiaojing
WANG Jie
LIU Qiuhua
WANG Yican
MA Yibin
CAI Yanru
YANG Qian
GUO Yuxi
Related Institution
The First Affiliated Hospital of Hebei University of Chinese Medicine
Hebei Key Laboratory of Turbidity Toxin Syndrome
Hebei University of Chinese Medicine
Graduate School, Hebei University of Chinese Medicine
Hebei Provincial Key Laboratory of Turbid Toxin Syndrome


